07Dec
Private Equity Dealmakers Guidebook to Healthcare M&A During the Covid-19 Pandemic
The COVID-19 pandemic has stressed the M&A market at every stage of the deal-making process – from complicating on-site visits and intensifying the diligence process to introducing valuation gaps (relative to pre-COVID-19 expectations), complicating purchase agreement negotiations and limiting the availability of debt financing. Despite these hurdles, healthcare dealmakers have continued to pursue attractive acquisition opportunities throughout 2020, with the healthcare M&A market substantially...
By:
Bass, Berry & Sims PLC
Related
A common challenge for employers of hourly or nonexempt employees who receive quarterly or annual no...
Read More >
Our Environment, Land Use & Natural Resources Group deconstructs the California State Water Resource...
Read More >
On August 12, 2019, Governor Andrew Cuomo signed into law S.6577, a bill implementing a series of sw...
Read More >
An inverse condemnation challenge to a permit denial is not ripe until the government makes a final ...
Read More >
Seyfarth Synopsis: In an unusual opinion considering an issue raised by the plaintiff for the first ...
Read More >
Activist investor Third Point LLC and three funds that it controls have agreed to settle Federal Tra...
Read More >